AAAAAA
Results:
1-18
|
Results: 18
Authors:
Schellenberg, F
Nalpas, B
Citation: F. Schellenberg et B. Nalpas, Incoming markers of alcohol abuse., PATH BIOL, 49(9), 2001, pp. 775-780
Authors:
Brechot, C
Thiers, V
Kremsdorf, D
Nalpas, B
Pol, S
Paterlini-Brechot, P
Citation: C. Brechot et al., Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely "occult"?, HEPATOLOGY, 34(1), 2001, pp. 194-203
Authors:
Nalpas, B
Martin, S
Fontaine, H
Fabbro-Peray, P
Brechot, C
Pol, S
Citation: B. Nalpas et al., Impact of medical recommendations on alcohol consumption in HCV positive patients, J HEPATOL, 35(2), 2001, pp. 312-313
Authors:
Pol, S
Nalpas, B
Driss, F
Michel, ML
Tiollais, P
Denis, J
Brechot, C
Citation: S. Pol et al., Efficacy and limitations of a specific immunotherapy in chronic hepatitis B, J HEPATOL, 34(6), 2001, pp. 917-921
Authors:
Fontaine, H
Nalpas, B
Carnot, F
Brechot, B
Pol, S
Citation: H. Fontaine et al., Effect of pregnancy on chronic hepatitis C - Reply, LANCET, 357(9253), 2001, pp. 389-390
Authors:
Fontaine, H
Nalpas, B
Poulet, B
Carnot, F
Zylberberg, H
Brechot, C
Pol, S
Citation: H. Fontaine et al., Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C, HUMAN PATH, 32(9), 2001, pp. 904-909
Authors:
Nalpas, B
Zylberberg, H
Dubois, F
Presles, MA
Gillant, JC
Lienard, M
Delemotte, B
Brechot, C
Citation: B. Nalpas et al., Prevalence of infection by hepatitis viruses in a rural area. Analysis according to risk factors and alcohol consumption, GASTRO CL B, 24(5), 2000, pp. 536-540
Authors:
Pol, S
Nalpas, B
Bourliere, M
Couzigou, P
Tran, A
Abergel, A
Zarski, JP
Berthelot, P
Brechot, C
Citation: S. Pol et al., Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C, HEPATOLOGY, 31(6), 2000, pp. 1338-1344
Authors:
Zylberberg, H
Nalpas, B
Pol, S
Brechot, C
Viard, JP
Citation: H. Zylberberg et al., Is there a relationship between hepatitis C virus infection and antiretroviral-associated lipoatrophy?, AIDS, 14(13), 2000, pp. 2055-2055
Authors:
Tuveri, R
Jaffredo, F
Lunel, F
Nalpas, B
Pol, S
Feray, C
Marcellin, P
Thibault, V
Delagneau, JF
Opolon, P
Scarpa, B
Brechot, C
Thiers, V
Citation: R. Tuveri et al., Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseases, J HEPATOL, 33(1), 2000, pp. 121-127
Authors:
Fontaine, H
Nalpas, B
Carnot, F
Brechot, C
Pol, S
Citation: H. Fontaine et al., Effect of pregnancy on chronic hepatitis C: a case-control study, LANCET, 356(9238), 2000, pp. 1328-1329
Authors:
Mejean, A
Vona, G
Nalpas, B
Damotte, D
Brousse, N
Chretien, Y
Dufour, B
Lacour, B
Brechot, C
Paterlini-Brechot, P
Citation: A. Mejean et al., Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence, J UROL, 163(6), 2000, pp. 2022-2029
Authors:
Fontaine, H
Vassault, A
Nalpas, B
Citation: H. Fontaine et al., Alcohol and the liver., PATH BIOL, 47(9), 1999, pp. 945-957
Authors:
Zylberberg, H
Pol, S
Thiers, V
Chaix, ML
Lagorce, D
Brechot, C
Nalpas, B
Berthelot, P
Citation: H. Zylberberg et al., Significance of repeatedly normal aminotransferase activities in HCV-infected patients, J CLIN GAST, 29(1), 1999, pp. 71-75
Authors:
Marcellin, P
Alberti, A
Dusheiko, G
Esteban, R
Manns, M
Shouval, D
Weiland, O
Williams, R
Benhamou, JP
Rodes, J
Alter, H
Bismuth, H
Desmet, V
Guardia, J
Heathcote, J
Lok, A
Maddrey, WC
Zum Buschenfelde, KHM
Pagliaro, L
Paumgartner, G
Sherlock, S
Abrignani, S
Alberti, A
Alter, M
Bonino, F
Bortolotti, F
Brechot, C
de Moura, MC
Carreno, V
Colombo, M
Craxi, A
Davis, G
De Francesco, R
Degos, F
Di Bisceglie, A
Dienes, H
Dusheiko, G
Esteban, J
Esteban, R
Farci, P
Ferrari, C
Foster, G
Hadziyannis, S
Hoofnagle, J
Koff, R
Lavanchy, D
Lindsay, K
Lunel, F
Manns, M
Marcellin, P
Mondelli, M
Nalpas, B
Naoumov, N
Pawlotsky, JM
Pol, S
Pontisso, P
Poynard, T
Prieto, J
Rizzetto, M
Roggendorf, M
Moreno, MR
Samuel, D
Sanchez-Tapias, J
Schalm, S
Shouval, D
Simmonds, P
Soriano, V
Tassopoulos, N
Thomas, H
Trepo, C
Van der Poel, CL
Vogel, W
Weiland, O
Wejstal, R
Williams, R
Wright, T
Zanetti, A
Zarski, JP
Zeuzem, S
Zoulim, F
Citation: P. Marcellin et al., EASL International Consensus Conference on Hepatitis C - Paris, 26-27 February 1999 - Consensus statement (Reprinted from Journal of Hematology, vol 30, pg 956-961, 1999), J HEPATOL, 31, 1999, pp. 3-8
Authors:
Nalpas, B
Desenclos, JC
Delaroque-Astagneau, E
Drucker, J
Citation: B. Nalpas et al., Management of hepatitis C by European hepatologists, J HEPATOL, 31, 1999, pp. 141-145
Authors:
Zylberberg, H
Fontaine, H
Thepot, V
Nalpas, B
Brechot, C
Pol, S
Citation: H. Zylberberg et al., Triggering of acute alcoholic hepatitis by alpha-interferon therapy, J HEPATOL, 30(4), 1999, pp. 722-725
Authors:
Nalpas, B
Desenclos, JC
Delarocque-Astagneau, E
Drucker, J
Citation: B. Nalpas et al., State of epidemiological knowledge and national management of hepatitis C virus infection in the European Community, 1996, EUR J PUB H, 8(4), 1998, pp. 305-312
Risultati:
1-18
|